(Q50508677)

14 March 2018

title

Transtympanic gentamicin in the treatment of Meniére's disease. (English)

1 reference

14 March 2018

0 references

Sala T

1

1 reference

14 March 2018

publication date

1 July 1997

1 reference

14 March 2018

number of pages

8

1 reference

inferred from page(s)

published in

Auris Nasus Larynx

1 reference

14 March 2018

volume

24

1 reference

14 March 2018

issue

3

1 reference

14 March 2018

page(s)

239-246

1 reference

14 March 2018

Meniere's syndrome and endolymphatic hydrops. Double-blind temporal bone study

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0385-8146%2897%2900017-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0385-8146%2897%2900017-5

1 reference

7 January 2021

Efficacy of Long-Term Administration of Isosorbide for Ménière’s Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0385-8146%2897%2900017-5

7 January 2021

Intratympanic gentamycin therapy for Menière's disease placed by tubal catheter with systemic isosorbide

1 reference

https://api.crossref.org/works/10.1016%2FS0385-8146%2897%2900017-5

7 January 2021

The ultrastructural organisation of "plana semilunata"

1 reference

https://api.crossref.org/works/10.1016%2FS0385-8146%2897%2900017-5

7 January 2021

Distribution, structure, and function of dark cells in the vestibular labyrinth

1 reference

https://api.crossref.org/works/10.1016%2FS0385-8146%2897%2900017-5

7 January 2021

The Histochemistry of Dark Cells in the Vestibular Labyrinth

1 reference

https://api.crossref.org/works/10.1016%2FS0385-8146%2897%2900017-5

7 January 2021

Experiments on Ototoxic Effects of Antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS0385-8146%2897%2900017-5

7 January 2021

Melanocytes of the Vestibular Labyrinth and Their Relationship to the Microvasculature

1 reference

https://api.crossref.org/works/10.1016%2FS0385-8146%2897%2900017-5

7 January 2021

Accumulation of substances with melanin affinity to the internal ear. Therapeutic or ototoxic mechanism?

1 reference

https://api.crossref.org/works/10.1016%2FS0385-8146%2897%2900017-5

7 January 2021

Clinical monitoring of the effects of gentamicin by electrocochleography.

1 reference

https://api.crossref.org/works/10.1016%2FS0385-8146%2897%2900017-5

7 January 2021

Distribution of gentamicin by immunofluorescence in the guinea pig inner ear.

1 reference

https://api.crossref.org/works/10.1016%2FS0385-8146%2897%2900017-5

7 January 2021

Gentamicin tympanoclysis: effects on the vestibular secretory cells

1 reference

https://api.crossref.org/works/10.1016%2FS0385-8146%2897%2900017-5

7 January 2021

Aminoglycoside-induced hearing loss: a molecular hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0385-8146%2897%2900017-5

7 January 2021

Toxic effects on inner ear of noxious agents passing through the round window membrane

1 reference

https://api.crossref.org/works/10.1016%2FS0385-8146%2897%2900017-5

7 January 2021

Review of round window membrane permeability

1 reference

https://api.crossref.org/works/10.1016%2FS0385-8146%2897%2900017-5

7 January 2021

Effect of gentamycin on vestibular dark cells and melanocytes: an ultrastructural and cytochemical study

1 reference

https://api.crossref.org/works/10.1016%2FS0385-8146%2897%2900017-5

7 January 2021

Middle Ear Ototoxic Treatment for Inner Ear Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0385-8146%2897%2900017-5

7 January 2021

The treatment of endolymphatic hydrops (Ménière's disease) with streptomycin

1 reference

https://api.crossref.org/works/10.1016%2FS0385-8146%2897%2900017-5

7 January 2021

Streptomycin treatment for Meniere's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0385-8146%2897%2900017-5

7 January 2021

Titration streptomycin therapy for bilateral Meniére's disease. Follow-up report

1 reference

https://api.crossref.org/works/10.1016%2FS0385-8146%2897%2900017-5

7 January 2021

Use of streptomycin sulfate in the treatment of Meniere's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0385-8146%2897%2900017-5

7 January 2021

Aminoglycoside ototoxicity in the human

1 reference

https://api.crossref.org/works/10.1016%2FS0385-8146%2897%2900017-5

7 January 2021

Transtympanic administration of aminoglycosides in patients with Menière's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0385-8146%2897%2900017-5

7 January 2021

10 years of experience with intratympanally applied streptomycin (gentamycin) in the therapy of Morbus Menière

1 reference

https://api.crossref.org/works/10.1016%2FS0385-8146%2897%2900017-5

7 January 2021

Gentamicin and other ototoxic antibiotics for the transtympanic treatment of Menière's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0385-8146%2897%2900017-5

7 January 2021

[Long-term results of gentamycin therapy of Menière's disease]

1 reference

https://api.crossref.org/works/10.1016%2FS0385-8146%2897%2900017-5

7 January 2021

Intratympanic gentamycin in severe Ménière's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0385-8146%2897%2900017-5

7 January 2021

Delayed onset of ototoxic effects of gentamicin in treatment of Menière's disease. Rationale for extremely low dose therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0385-8146%2897%2900017-5

7 January 2021

Intratympanic application of gentamicin for treatment of Menière's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0385-8146%2897%2900017-5

7 January 2021

Effect of intratympanically administered gentamicin on hearing and tinnitus in Menière's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0385-8146%2897%2900017-5

7 January 2021

Autoimmune Sensorineural Hearing Loss

1 reference

https://api.crossref.org/works/10.1016%2FS0385-8146%2897%2900017-5

7 January 2021

Immunologic study on the inner ear. Immunoglobulins in perilymph.

1 reference

https://api.crossref.org/works/10.1016%2FS0385-8146%2897%2900017-5

7 January 2021

Human endolymphatic sac: evidence for a role in inner ear immune defence

1 reference

https://api.crossref.org/works/10.1016%2FS0385-8146%2897%2900017-5

7 January 2021

Immunological approach to Ménière's disease: vestibular immune injury following immune reaction of the endolymphatic sac.

1 reference

https://api.crossref.org/works/10.1016%2FS0385-8146%2897%2900017-5

7 January 2021

Ototoxicity of Gentamicin in Man: A Survey and Controlled Analysis of Clinical Experience in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0385-8146%2897%2900017-5

7 January 2021

Survey of interactions between middle ear and inner ear.

1 reference

https://api.crossref.org/works/10.1016%2FS0385-8146%2897%2900017-5

7 January 2021

The effect of gentamicin on the glycocalyx and the ciliary interconnections in vestibular sensory cells: a high resolution scanning electron microscopic investigation

1 reference

https://api.crossref.org/works/10.1016%2FS0385-8146%2897%2900017-5

7 January 2021

Intratympanic gentamicin in bilateral Menière's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0385-8146%2897%2900017-5

7 January 2021

Gentamicin treatment in peripheral vestibular disorders other than Ménière's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0385-8146%2897%2900017-5

7 January 2021

10.1016/S0385-8146(97)00017-5

Identifiers

DOI

1 reference

14 March 2018

1 reference

14 March 2018